(OGI) Organigram Global Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(OGI) Organigram Global Inc. Complete Analysis Pack
This Organigram Global Inc. 4P's Marketing Mix Analysis summarizes the company’s Product, Price, Place, and Promotion strategy in a concise, actionable format and is designed for marketing research, benchmarking, and strategic planning. The page shows a genuine preview/sample of the report so you can evaluate style and substance—purchase the full version to download the complete ready-to-use analysis.
Product
Organigram Global Inc. sells dried cannabis flower as a core product, and it feeds both adult-use and medical channels. In fiscal 2024, Organigram reported net revenue of C$161.6 million, showing flower still matters to the mix. The same base input also supports derivative formats, while the company sells it through premium and value brands.
Pre-rolls are one of Organigram Global Inc.’s key finished-product formats, built for convenience-led buying and faster use. The company sells them across brand families such as SHRED, Edison, and Trailblazer, which helps it serve both value and premium shoppers. In retail, pre-rolls fit single-unit trial and multi-pack baskets, a format that supports repeat purchase and shelf velocity.
Organigram Global Inc. sells cannabis oils and vapor products for medical users, giving patients 2 non-combustion options. These formats support dose control and easier use, which matters for patients who want consistent intake without smoking. The line also broadens Organigram beyond dried flower, strengthening its medical product mix.
Edibles and Gummies
Organigram Global Inc. sells edible cannabis products, including gummies, in its branded adult-use portfolio. These formats target adult consumers who want discreet use, and they help widen the Company Name mix beyond dried flower and vapes. In Canada, edibles are a key legal category for market breadth, so gummies support shelf presence and repeat purchase.
- Adult-use, branded recreational line
- Discreet format for consumers
- Broadens product assortment
Concentrates and Derivatives
Organigram Global Inc. supplies concentrates and cannabis derivatives, including proprietary blends and processed formats, to support higher-value, innovation-led sales. These products also feed its wholesale channel, giving the Company more mix control than flower alone.
- Higher-value derivative formats
- Supports wholesale sales
- Uses proprietary blends
- Processed, innovation-led offerings
Organigram Global Inc. products center on dried flower, pre-rolls, oils, vapes, edibles, and concentrates, spanning adult-use and medical demand. Fiscal 2024 net revenue was C$161.6 million, so flower still anchors the mix. Pre-rolls and gummies widen reach, while derivatives lift value per gram.
| Product | Role |
|---|---|
| Flower | Core revenue |
| Pre-rolls | Convenience |
| Edibles | Discreet use |
What is included in the product
Detailed Word Document
Provides a concise, company-specific 4P analysis of Organigram Global Inc.’s Product, Price, Place, and Promotion strategy.
Editable Excel File
Condenses Organigram Global Inc.’s 4Ps into a quick, clear snapshot that reduces analysis overload and speeds decision-making.
Reference Sources
Provides a concise, traceable list of primary sources (industry reports, govt data, benchmarks) to speed due diligence and validate Organigram Global Inc. assumptions.
Place
Organigram Global Inc.’s online platform gives customers direct access to listed cannabis products for both medical and adult-use orders, so it can reach buyers beyond physical stores. This channel matters in Canada’s legal market, where online fulfillment helps broaden access and support repeat purchases while keeping the brand visible across provinces.
Organigram Global Inc. accepts telephone orders, giving customers a direct-sales path and helping buyers who want assisted ordering. This matters in service-led medical transactions, where a live agent can speed up product selection and order handling. In fiscal 2025, that support sat alongside Organigram’s broader direct-to-consumer and medical channels, which the company continued to scale.
Organigram Global Inc. reaches adult-use shoppers through Canada’s provincial retail systems, which control shelf access and placement. Canada has 10 provinces, and each one sets its own cannabis distribution rules, so retail reach depends on provincial boards and licensed stores. This is Organigram Global Inc.’s main route to recreational market availability.
Wholesale Supply Chain
Organigram Global Inc. uses wholesale to sell cuttings, dried flower, pre-rolls, and derivatives to retailers and other wholesalers, so it acts as both brand owner and supplier. In FY2025, this channel helped widen geographic reach and raise shipment volume without relying only on direct retail. That mix gives Organigram more shelf access and a bigger addressable market.
- Reaches retailers and other wholesalers
- Moves multiple product formats
- Supports brand and supply roles
- Expands volume and market reach
Moncton Headquarters
Organigram Global Inc. is headquartered in Moncton, Canada, and the site anchors corporate and operating control for its Canadian base. It helps coordinate cultivation, production, and distribution across the business, which reported FY2025 net revenue of C$321.3 million and held C$108.4 million in cash and cash equivalents at quarter-end.
- Moncton is the control center.
- Supports Canada-wide operations.
- Backs cultivation and production oversight.
Place for Organigram Global Inc. is multi-channel: online, phone, provincial retail, and wholesale. In FY2025, that mix supported C$321.3 million in net revenue and widened access across Canada’s 10 provinces. Moncton anchors control and helps coordinate cultivation, production, and distribution.
| Place channel | FY2025 role |
|---|---|
| Online | Direct access |
| Phone | Assisted orders |
| Retail and wholesale | Canada-wide reach |
Preview the Actual Deliverable
Organigram Global Inc. Reference Sources
The preview shown here is the actual Organigram Global Inc. 4P's Marketing Mix document you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.
Promotion
Edison Cannabis Co. is one of Organigram Global Inc.’s consumer brands, and brand-led promotion matters in a regulated market where ads are limited. Canada’s adult-use cannabis market was about C$4.5 billion in 2024, so Edison’s premium packaging and product names help it stand out and support higher-value positioning. That makes the brand a key tool for awareness and repeat purchase.
SHRED is Organigram Global Inc.'s value-led brand platform, built to signal affordability and convenience in high-volume consumer formats. In fiscal 2025, that matters because Organigram kept pushing everyday-use products where price and pack size drive repeat buys. The brand messaging stays simple: accessible, no-frills, and made for regular use.
Organigram Global Inc. uses medical patient outreach to educate patients and veterans on oils, flowers, and vapor products, with service details that help build trust and repeat care. In fiscal 2025, that channel stayed focused on product guidance and continuity, which matters when medical buyers want consistent formats and dosing support.
Retail and Trade Support
Organigram Global Inc. uses retail and wholesale ties to keep products on shelves and in front of buyers across Canada’s 10 provincial markets. Trade support backs launches, improves shelf placement, and keeps brand awareness high where province-by-province rules shape access and speed to market.
- Shelf presence drives sell-through.
- Wholesale links support launches.
- Provincial rules make execution critical.
Corporate Communications
Organigram Global Inc. uses quarterly reports, MD&A, and investor decks to show strategy and results, so public reporting doubles as promotion. In fiscal 2025, net revenue was C$162.5 million and adjusted EBITDA was C$14.7 million, giving market stakeholders hard proof of execution and helping strengthen brand credibility.
- Fiscal 2025 net revenue: C$162.5 million
- Fiscal 2025 adjusted EBITDA: C$14.7 million
- Investor reporting supports visibility
- Public disclosure builds market trust
Organigram Global Inc. promotes through brand-led packaging, trade support, medical outreach, and investor reporting because cannabis ads are limited. In fiscal 2025, net revenue was C$162.5 million and adjusted EBITDA was C$14.7 million, so disclosure also works as proof of execution.
Edison targets premium buyers, SHRED pushes value and convenience, and both help drive shelf pull-through in Canada’s regulated market.
| Channel | Role |
|---|---|
| Brands | Awareness |
| Trade | Shelf support |
| Investor reporting | Credibility |
Price
Edison is priced in Organigram Global Inc.'s premium cannabis tier, so the brand can lean on quality, format, and stronger shelf appeal. Premium pricing fits adult-use retail because it supports higher perceived value and gives the product an upscale signal. That price ladder also helps Organigram Global Inc. protect margins while keeping Edison aligned with a premium brand position.
SHRED uses value-oriented pricing, aimed at consumers who want lower price points and steady everyday use. That lets Organigram compete on affordability while reaching a wider income range. In a market where price sensitivity stays high, SHRED helps defend share in the value tier and supports volume-led sales.
Trail Blazer is priced for low-friction, entry-level buys, giving Organigram Global Inc. a value-led option for consumers who want a simple, affordable choice. In fiscal 2025, Organigram Global Inc. reported net revenue of about C$195 million, and this price tier helps support volume in recreational channels. That positioning fits the brand’s job: drive repeat purchases without pushing buyers into premium spend.
Bulk Big Bag O' Buds Pricing
Bulk Big Bag O' Buds uses larger-format packs to push down cost per gram, a common value move in cannabis retail. That fits price-sensitive buyers and repeat users, especially as Organigram Global Inc. reported net revenue of about C$182.2 million in fiscal 2025, showing scale in value-led formats. Bigger bags make price feel easier to justify at shelf.
- Lower cost per gram
- Targets value buyers
- Supports repeat purchase
Wholesale and Provincial Pricing
Wholesale pricing drives Organigram Global Inc.’s supply revenue, but the shelf price is set later by province, retailer margin, and taxes. In Canada, cannabis pricing is channel-specific: adult-use and medical SKUs can carry different price points, and provincial take rates plus sales tax can shift the final consumer price by several dollars per gram.
- Wholesale first; retail later
- Province sets final shelf price
- Medical and adult-use can differ
- Taxes and retailer margin move price
Organigram Global Inc. uses a clear price ladder: Edison sits premium, SHRED and Trail Blazer target value, and Bulk Big Bag O' Buds cuts cost per gram for repeat buyers. In fiscal 2025, Organigram Global Inc. reported net revenue of about C$195 million, while value packs helped support about C$182.2 million in recreational scale.
| Brand | Price role | Use |
|---|---|---|
| Edison | Premium | Higher-margin shelf signal |
| SHRED | Value | Broad reach |
| Trail Blazer | Entry value | Repeat buys |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
